Clinical Trial Update: Cell Therapy for Corneal Endothelial Cell Dysfunction [Phase 1]

View source ↗

Summary

A Phase 1 cell therapy trial for corneal endothelial cell dysfunction is currently enrolling by invitation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Corneal Endothelial Cell Dysfunction

Drugs mentioned

• Corneal Endothelial Cell Therapy

Snippet

Sponsor: National Taiwan University Hospital | Conditions: Corneal Endothelial Cell Dysfunction | Phase 1 | Status: ENROLLING_BY_INVITATION